Cargando…

Update on hepatocellular carcinoma: Pathologists’ review

Histopathologic diversity and several distinct histologic subtypes of hepatocellular carcinoma (HCC) are well-recognized. Recent advances in molecular pathology and growing knowledge about the biology associated with distinct histologic features and immuno-profile in HCC allowed pathologists to upda...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Jabbour, Tony, Lagana, Stephen M, Lee, Hwajeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465943/ https://www.ncbi.nlm.nih.gov/pubmed/31011252 http://dx.doi.org/10.3748/wjg.v25.i14.1653

Ejemplares similares

Composite intestinal adenoma-microcarcinoid: An update and literature review
por: Fu, Zhi-Yan, et al.
Publicado: (2021)

Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate
por: Aldyab, Mahmoud, et al.
Publicado: (2021)

Targets of immunotherapy for hepatocellular carcinoma: An update
por: Rai, Vikrant, et al.
Publicado: (2022)

Pathologic and molecular features of hepatocellular carcinoma: An update
por: Vij, Mukul, et al.
Publicado: (2021)

Pediatric vascular tumors of the liver: Review from the pathologist’s point of view
por: Cordier, Fleur, et al.
Publicado: (2021)

Management of centrally located hepatocellular carcinoma: Update 2016
por: Yu, Wei-Bo, et al.
Publicado: (2017)

Recent update on comprehensive therapy for advanced hepatocellular carcinoma
por: Wang, Hui, et al.
Publicado: (2021)

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
por: Hanif, Hira, et al.
Publicado: (2022)

Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints
por: Park, Sunmin, et al.
Publicado: (2020)

Hepatic Langerhans cell histiocytosis: A review
por: Fu, Zhiyan, et al.
Publicado: (2021)

Plexiform fibromyxoma: Review of rare mesenchymal gastric neoplasm and its differential diagnosis
por: Arslan, Mustafa Erdem, et al.
Publicado: (2021)

Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review
por: Li, Hua, et al.
Publicado: (2021)

Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017)

Nutritional therapy for hepatocellular carcinoma
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023)

Application of artificial intelligence in the diagnosis and treatment of hepatocellular carcinoma: A review
por: Jiménez Pérez, Miguel, et al.
Publicado: (2020)

Molecular therapy for the treatment of hepatocellular carcinoma
por: Greten, T F, et al.
Publicado: (2009)

Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist
por: Quaglia, Alberto
Publicado: (2018)

Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
por: Gerum, Sabine, et al.
Publicado: (2019)

Hepatocellular carcinoma surveillance: An evidence-based approach
por: Harris, Patrick S, et al.
Publicado: (2019)

Hepatocellular carcinoma – time to take the ticket
por: Mullath, Anju, et al.
Publicado: (2019)

Dimensions of hepatocellular carcinoma phenotypic diversity
por: Désert, Romain, et al.
Publicado: (2018)

Characterization of metabolic landscape in hepatocellular carcinoma
por: Wu, Jing, et al.
Publicado: (2021)

Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022)

The mononuclear phagocyte system in hepatocellular carcinoma
por: Qiao, Duan-Rui, et al.
Publicado: (2022)

Systemic treatment for unresectable hepatocellular carcinoma
por: Leowattana, Wattana, et al.
Publicado: (2023)

Ablative strategies for recurrent hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2023)

Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
por: Lee, Byung Min, et al.
Publicado: (2021)

Liver manifestations in COVID-19 patients: A review article
por: Helou, Mariana, et al.
Publicado: (2023)

Update on diagnosis and treatment of early signet-ring cell gastric carcinoma: A literature review
por: Tang, Yun-He, et al.
Publicado: (2023)

Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
por: Hsu, Che-Yu, et al.
Publicado: (2019)

Anatomical resection of hepatocellular carcinoma: A critical review of the procedure and its benefits on survival
por: Kang, Koo Jeong, et al.
Publicado: (2017)

Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016)

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
por: Lee, Hye Won, et al.
Publicado: (2016)

Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
por: Cassese, Gianluca, et al.
Publicado: (2022)

Apatinib as an alternative therapy for advanced hepatocellular carcinoma
por: Zhang, Xi-Hao, et al.
Publicado: (2020)

Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
por: Chen, Pu, et al.
Publicado: (2021)

Radiomics for the detection of microvascular invasion in hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2022)

Bile acids as drivers and biomarkers of hepatocellular carcinoma
por: Colosimo, Santo, et al.
Publicado: (2022)

Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center
por: Maloberti, Thais, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_thgs830g80ts0cpdkr660ilqds